News | Cardiovascular Business | April 29, 2019

Fail-safe Program for New Medical Technology Focuses on Patient Safety

Symposium in AACN Advanced Critical Care journal provides an overview of processes and strategies to successfully integrate innovative devices and technology into patient care

Fail-safe Program for New Medical Technology Focuses on Patient Safety

April 29, 2019 — New medical technology offers the promise of improving patient care, as well as the potential for harm if caregivers are not sufficiently educated about its operation and use. Without a comprehensive approach, caregivers may learn how to use complex technology at the patient’s bedside, through trial and error, instruction manuals or informally from their colleagues. An article in AACN Advanced Critical Care1 describes how Memorial Hermann Health System in Houston developed an interdisciplinary fail-safe process to analyze and scale training for use of medical devices, with a risk assessment tool to predict the severity and frequency of potential harm to patients.

One of the largest not-for-profit health systems in southeast Texas, Memorial Hermann has 14 hospitals of its own, five others operated through joint ventures, and numerous specialty programs and services throughout the Greater Houston area. From 2012 through 2018, more than 100 medical devices have gone through its fail-safe assessment, with 46 percent receiving the highest level of scrutiny and education due to the risk assessment.

The journal article, “Optimizing Fail-Safe Use of Complex Medical Devices,” describes the key factors that contribute to adverse patient safety events and the principles underlying high-reliability organizations. The article includes the tools and worksheets used by Memorial Hermann staff for each phase of the process, from initial device request through compliance tracking and reporting. Four case scenarios summarize how the fail-safe review was applied to different clinical situations and review the outcomes of the education required before rollout of the device.

Co-author M. Michael Shabot, M.D., is executive vice president and chief clinical officer for Memorial Hermann.

“Patient safety has been our single core value for more than 10 years,” Shabot said. “The fail-safe process exemplifies our commitment to ensuring patient safety, preventing harm and using high-reliability principles at every level of the organization. Given the growing complexity of technology, clinician education and training are crucial to patient safety.”

Memorial Hermann’s fail-safe process is designed to eliminate human error during medical device use through standardized and evidence-based education and training.

Before a medical device is approved for patient care or even enters the fail-safe process, it undergoes an in-depth evaluation led by the supply chain department. The evaluation includes a cost-analysis review, trial use and feedback from stakeholders and end-users.

Medical devices that qualify for fail-safe assessment can be new devices, those with new functionality or updates, or substitute or replacement technology.

After a device is evaluated and approved for purchase, the process assesses potential risks, identifies varying levels of required education and training, and mandates competency reporting. Integrating new technology into patient care requires that clinical staff be competent in the operation of all approved new and updated medical devices.

The article is part of a symposium published in the spring 2019 issue of the peer-reviewed AACN Advanced Critical Care that addresses several key facets of selecting and implementing complex patient care technology.

JoAnne Phillips, DNP, RN, CNS, CPPS, served as editor for the symposium. She is director of clinical practice at Virtua Health System in Marlton, N.J.

“Complex patient care technology is no longer limited to operating rooms and critical care units and can be found through the continuum of care,” she said. “The articles in this symposium focus on processes and strategies that can be used to successfully integrate innovative devices and technology into patient care.”

For more information: www.acc.aacnjournals.org

 

Reference

1. Hercules P., Shabot M.M., Ryan T., et al. Optimizing Fail-Safe Use of Complex Medical Devices. AACN Advanced Critical Care, Spring 2019. doi: 10.4037/aacnacc2019400


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now